Senaste försöken

EudraCT Number: 2004-001301-10

Sponsor Protocol Number: EOP1009

Start Date: 2004-06-14

Sponsor Name: PFIZER

Full Title: A PHASE II PROSPECTIVE, RANDOMIZED, DOUBLE-MASKED, SHAM-CONTROLLED, DOSE-RANGING, MULTI-CENTER TRIAL TO ASSESS THE EFFECT OF PEGAPTANIB SODIUM ON FOVEAL THICKENING IN PATIENTS WITH EXUDATIVE SUBFOV...

Medical condition: AGE-RELATED MACULAR DEGENERATION

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10025409		PT

Population Age: Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2004-000603-18

Sponsor Protocol Number: Q10DOWN

Start Date: 2004-06-11

Sponsor Name: AZIENDA OSPEDALIERA UMBERTO I

Full Title: ubiquinone in Down syndrome

Medical condition: Down syndrome

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2004-000507-17

Sponsor Protocol Number: SC1-04

Start Date: 2004-06-10

Sponsor Name: FONDAZIONE SANTA LUCIA

Full Title: Effectiveness of rivastigmine treatment in post-stroke patients with right brain damage and unilateral spatial neglect

Medical condition: Improvement of unilateral spatial neglect and functional status in right brain damaged patients

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-000782-35

Sponsor Protocol Number: CERL080AIT06

Start Date: 2004-06-10

Sponsor Name: NOVARTIS FARMA

Full Title: EVALUATION OF THE QUALITY OF LIFE AND GASTROINTESTINAL SYMPTOMS AFTER CONVERSION TO MYFORTIC (ERL080) and CELLCEPT WITHDRAWAL IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS TREATED WITH TACROLIMUS.

Medical condition: Prophylaxis of transplant rejection in adult patients receiving calcineurin inhibitors with / without corticosteroids after allogeneic renal transplants.

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10023439		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2004-000374-31

Sponsor Protocol Number: SB-683699/003

Start Date: 2004-06-09

Sponsor Name: GLAXO SMITHKLINE

Full Title: A Randomised, Double-blind, Placebo-controlled, Parallel Group, Dose-Ranging Study to Investigate the Efficacy and Safety of Three Months administration of SB 683699 (150 - 1200mg twice daily) in ...

Medical condition: Relapsing Multiple Sclerosis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2009-017840-15

Sponsor Protocol Number: KS-2003-06

Start Date: 2004-05-31

Sponsor Name: DSC Services, s.r.o.

Full Title: Srovnání účinnosti kapecitabinu (Xeloda) s kontinuálním podáním 5-fluorouracilu v předoperační konkomitantní léčbě s radioterapií u karcinomu rekta

Medical condition: Rectal cancer stage II and III

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Completed)

Trial results: (No results available)

EudraCT Number: 2004-000376-14

Sponsor Protocol Number: CLAF237A2309

Start Date: 2004-05-28

Sponsor Name: NOVARTIS FARMA

Full Title: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, ACTIVE CONTROLLED STUDY TO COMPARE THE EFFECT OF 52 WEEKS TREATMENT WITH LAF237 50 MG BID TO METFORMIN UP TO 1000 MG BID IN DRUG NAIVE PATIENTS WITH TYPE 2 ...

Medical condition: MONOTHERAPY TREATMENT OF PATIENTS WITH TYPE 2 DIABETES

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10012601		PT

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2004-000349-40

Sponsor Protocol Number: H8O-MC-GWAO

Start Date: 2004-05-19

Sponsor Name: ELI LILLY

Full Title: Efficacy of Exenatide Compared with Insulin Glargine in Patients with Type 2 Diabetes Using Metformin or Sulfonylurea for Whom Insulin is the Next Appropriate Therapy

Medical condition: Type 2 Diabetes Mellitus

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10012607		5

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2004-001321-25

Sponsor Protocol Number: 101596

Start Date: 2004-05-19

Sponsor Name: WYETH LEDERLE

Full Title: A prospective, open label, monocenter trial to evaluate the interaction between the Platelia Aspergillus ELISA test and the administration of piperacillin/tazobactam.

Medical condition: Evaluation of interference between platelia aspergillus ELISA TEST and administration of PIPERACILLIN/TAZOBACTAM.

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10004018		HLGT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2004-001035-32

Sponsor Protocol Number: ISG-STS 04/03

Start Date: 2004-05-13

Sponsor Name: ITALIAN SARCOMA GROUP

Full Title: NON-MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FROM HLA IDENTICAL SIBLING FOR METASTATIC SOFT TISSUE SARCOMAS

Medical condition: METASTATIC SOFT TISSUE SARCOMAS

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10029104	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	SOC

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Prematurely Ended)

Trial results: (No results available)

Senaste försöken

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner